SCHEMBL5960441

SCHEMBL5960441

Cc1c(O)cc(/C=C/c2ccccc2)cc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.64
ALOX5 P09917 3/20 0.64
PTGS2 P35354 3/20 0.64
TTR P02766 1/20 0.64
AHR P35869 1/20 0.63
TUBB1 Q9H4B7 2/20 0.55
TRPA1 O75762 1/20 0.52
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
MEN1 O00255 1/20 0.52
USP2 O75604 1/20 0.52
TP53 P04637 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
KMT2A Q03164 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
TRPV1 Q8NER1 1/20 0.52
HSD17B10 Q99714 1/20 0.52
PTPN1 P18031 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960445 1.00 PTGS1 (0.64) PTGS1ALOX5PTGS2TTRAHR
Acetic Acid SCHEMBL3403954 0.92 TTR (0.56) PTGS1ALOX5PTGS2TTRAHR
SCHEMBL18326527 0.83 PTGS1 (0.64) PTGS1ALOX5PTGS2TTRTUBB1
SCHEMBL18329574 0.83 PTGS1 (0.64) PTGS1ALOX5PTGS2TTRTRPA1
3,4,5-Trihydroxy-Transstilbene SCHEMBL41159 0.82 PTGS2 (0.63) PTGS1ALOX5PTGS2TTRAHR
3,4,5-Trihydroxy-Transstilbene SCHEMBL41160 0.82 PTGS2 (0.63) PTGS1ALOX5PTGS2TTRAHR
SCHEMBL10946633 0.78 PTGS1 (1.00) PTGS1ALOX5PTGS2TTR
SCHEMBL919450 0.78 AHR (0.58) PTGS1ALOX5PTGS2TTRAHR
SCHEMBL5960449 0.78 AHR (0.58) PTGS1ALOX5PTGS2TTRAHR
SCHEMBL12644239 0.78 PTGS1 (1.00) PTGS1ALOX5PTGS2TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 US disclosed
WO-2006004722-A2 COMPOSITIONS AND METHODS FOR SELECTIVELY ACTIVATING HUMAN SIRTUINS BIOMOL RESEARCH LABORATORIES, INC. (US) 2006-01-12 WO disclosed